Study looks at the role of MSUT2 in tau protein toxicity

Department news | October 31, 2017

Brian Kraemer, PhD, Adjunct Research Assistant Professor, has received funding from the National Institute on Aging to study the role of the tau protein in Alzheimer’s disease, using a variety of model organisms, including mouse, C. elegans worm, and human cell models of tau toxicity. Kraemer is a research associate professor in the UW Division […]


Osteoarthritis-related pain and insomnia study receives more funding

Department news | October 31, 2017

Michael V Vitiello, PhD, and his fellow multiple PIs; Susan McCurry, PhD, Research Professor of Psychosocial and Community Health Nursing, and Michael Von Korff, ScD, Senior Investigator, Kaiser Permanente Washington Health Research Institute (KPWHRI), have received a two-year, $372,000 Diversity Supplement to their National Institute on Aging-funded five-year randomized controlled trial, Efficacy of Scalable CBT-I […]


20-year follow-up to ACTIVE Study gets funded

Department news | October 31, 2017

Co-PIs, George Rebok, PhD, and Sherry Willis, PhD, were recently awarded $756k from NIH to do a 20-year follow-up to the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) study. This study is the largest randomized clinical trial to examine whether cognitive training enhances both cognitive abilities and everyday functioning in normal older adults. Findings […]


Philips to lead Neuroscience Group

Department news | September 30, 2017

Congratulations to Paul Phillips, PhD, for being appointed Co-Chair of the UW Graduate School’s Interdisciplinary Neuroscience Group and Co-Director of the UW Graduate Program in Neuroscience for a five year term beginning September, 2017. The Neuroscience program draws faculty from departments across campus and from affiliated institutes across Seattle to give researchers the opportunity to be trained across a wide […]


Trial evaluates app used during psychotherapy for PTSD

Department news | September 30, 2017

The Seattle Institute for Biomedical and Clinical Research (SIBCR) awarded Greg Reger, PhD, an intramural grant titled ‘Innovative Technologies to Support Service Member and Veteran Psychological Health.’ This grant will support a pilot randomized trial evaluating clinical outcomes related to the use of the PE Coach, a VA/DoD mobile application used during psychotherapy for PTSD. The […]


Psychiatry faculty and staff play big role at SIRC Biennial Conference

Department news | September 30, 2017

The Society for Implementation Research Collaboration (SIRC) held their 4th biennial conference at the University of Washington September 7-9. Over 30 Psychiatry and Behavioral Sciences faculty and staff participated in planning the conference and/or presenting their research. Several department faculty and staff serve as officers for SIRC, including Kate Comtois, PhD, Maria Monroe-DeVita, PhD, Aaron Lyon, PhD, Andria Pierson, Doyanne […]


Christine Lee awarded $2.49M five year NIAAA grant

Department news | September 30, 2017

Christine Lee, PhD, Research Professor and Associate Director of the Center for the Study of Health and Risk Behaviors, received a five year grant to develop and test a mobile app for college students that aims to reduce high-risk alcohol use and associated negative consequences. Funded by the National Institute on Alcohol Abuse and Alcoholism, […]


Reducing polypharmacy among veterans

Department news | September 30, 2017

Using multiple drugs simultaneously to treat a single ailment or condition, also known as polypharmacy, has increased over the past two decades among Veterans, exposing them to risks for drug-drug interactions and adverse side effects. Optimizing a Veteran’s medication regimen using a pharmacogenetic decision support tool – one based on how an individual’s genotype influences […]



Examining use of Prazosin on Alzheimer’s patients

Department news | September 30, 2017

Elaine Peskind, MD, and Murray Raskind, MD, received a $4.8 million award from the National Institute on Aging (through the UCSD-based Alzheimer’s Disease Cooperative Study) to lead a randomized controlled multicenter trial of prazosin for disruptive agitation in Alzheimer’s disease. Agitation is extremely common among patients with Alzheimer’s and leads to distress of both the patient […]